04/08/23 G.GUIDI - M.AMADORI : 4D TOMOTHERAPY : PRELIMINARY DOSIMETRIC ANALYSIS OF THE EFFECTS OF THE TARGET MOTION 1
Dedicata aCri
EMEA 2009 Tomotherapy User Meeting
4D TOMOTHERAPY : PRELIMINARY DOSIMETRIC ANALYSIS OF THE
EFFECTS OF THE TARGET MOTION
G.Guidi1, M.Amadori2, E.Cenacchi1, L.Morini1, C.Danielli1, F.Bertoni2
1 Medical Physics Dpt.2 U.O. Radiation OncologyAzienda Ospedaliero - Universitaria di Modena - Policlinico
“… under the “Ghirlandina” Tower….…..new opportunities and ideas are growing
……and many people are working on it”
04/08/23 G.GUIDI - M.AMADORI : 4D TOMOTHERAPY : PRELIMINARY DOSIMETRIC ANALYSIS OF THE EFFECTS OF THE TARGET MOTION 2
Dedicata aCri
CLINICAL RESEARCH – INTERCOMPARISON – TRIALS (TO ACQUIRE TOMOTHERAPY)
1. NSCLC : Efficacy and tolerances of exclusive and post-surgery radiation therapy treatments with/without chemo association, using CT-PET and Dynamic IMRT. Patients survivor and/or time progression analysis. Procedures and cost-benefit evaluation. (Prof. L.Fabbri, Prof. U.Morandi, Prof. B.Bagni, Dr. F.Bertoni, Dr. C.Danielli)
2. H&N : Radical treatments with chemo association using Dynamic IMRT, IGRT and Adaptive Radiation Therapy. Treatment conformity index, patients tolerance, efficacy and cost-benefit evaluation using Tomotherapy (Prof. P.F.Conte, Prof. A.Falchi, Dr. F.Bertoni, Dr. C.Danielli)
3. TBI (National Health Research - PIO V): Clinical and dosimetric evaluation of Total Body Irradiation using Tomotherapy. Transplant procedure, adequacy and safety evaluations of the treatments using Tomotherapy. Problem solving, efficacy and efficiency. (Prof. G.Torelli, Dr. F.Bertoni, Dr. C.Danielli)
4. PAEDIATRIC : Clinical evaluation of paediatric treatments. Paediatric patients management and performance assessment for high conformal and complex treatment using Tomotherapy. Clinical advantages and disadvantages. (Prof. P.Paulucci, Dr. F.Bertoni, Dr. C.Danielli)
5. BRAIN : Clinical study for upper-tentorial cerebral treatment using Tomotherapy. Clinical advantages and disadvantages, cost-benefit impact and patient management (Prof. G.Pinna, Dr. L.Mavilla, Prof. B.Bagni, Dr. F.Bertoni, Dr. C.Danielli)
6. TECHNOLOGY ASSESSMENT: Technical, dosimetric and cost-benefit evaluation of a Tomotherapy Unit. Routine applicability in a Public hospital for high conformal, IGRT and Adaptive Radiation Therapy treatment. Develop and optimization of treatment delivery, commissioning and Quality Assurance procedures. Time estimation and requirement to implement protocols and techniques (Dr. F.Bertoni, Dr. C.Danielli, Dr. Eng. M.Lugli)
TRIALS AND INTERCOMPARISON• IRMA – Partial Breast Irradiation (www.irmatrial.it)• CHPLT2008 A- H&N Multicentric Intercomparison • MESOTHELIOMA (Intercomparison IMRT vs. Tomotherapy vs. Protons)• NSCLC – Intercomparison CNAO (Photons - Protons)
04/08/23 G.GUIDI - M.AMADORI : 4D TOMOTHERAPY : PRELIMINARY DOSIMETRIC ANALYSIS OF THE EFFECTS OF THE TARGET MOTION 3
Dedicata aCri
LET’S START FROM WHO HAS MORE EXPERIENCES THAN US
04/08/23 G.GUIDI - M.AMADORI : 4D TOMOTHERAPY : PRELIMINARY DOSIMETRIC ANALYSIS OF THE EFFECTS OF THE TARGET MOTION 4
Dedicata aCri
RADIATION ONCOLOGY WORKFLOW ANALYSIS
Multi-modality Imaging
Immobilization
Verify and Monitor Delivery
Deliver Treatment
Pre-Verify Dose/Position
Simulation
Forward PlanningTreatment setup
Dose computation
Inverse PlanningDefine Objectives
Optimize
Plan Analysis
Dose Accuracy
Target and Structure Definition
Image Patient
Adaptive Analysis
Delivery System QA
Export to Delivery System
Pretreatment CT Guidance
Modify Plan/Patient Position
Planning
4D Components
Delivery
Export for Population
04/08/23 G.GUIDI - M.AMADORI : 4D TOMOTHERAPY : PRELIMINARY DOSIMETRIC ANALYSIS OF THE EFFECTS OF THE TARGET MOTION 5
Dedicata aCri
4D WORKFLOW ANALYSIS (4D TOOLS AND ISSUES)
Multi-modality Imaging
Immobilization
Verify and Monitor Delivery
Deliver Treatment
Pre-Verify Dose/Position
Simulation
Forward PlanningTreatment setup
Dose computation
Inverse PlanningDefine Objectives
Optimize
Plan Analysis
Dose Accuracy
Target and Structure Definition
Image Patient
Adaptive Analysis
Delivery System QA
Export to Delivery System
Pretreatment CT Guidance
Modify Plan/Patient Position
Planning
4D Components
Delivery
Export for Population
4D Images (>1000)
4D Tools & Issues
4D ContouringPropagate ROIs?MIP Contouring?4D OARs Volume Deformations
4D Planning (0-100% Phases)?4D Dose Computation – Phases?
4D Analysis (Multiple Plan)
4D QA (Dynamic Phantom)
4D Gamma Index?4D Dose Point?4D Edge Profile?Accuracy?
4D Inverse Planning(Same results?)
Which Plan or Phases?
Which Phases to be consider?
Trigger Tomotherapy is possible?
4D-MVCT?
Tracking the delivery
4D Adaptive RT Reconstruction
04/08/23 G.GUIDI - M.AMADORI : 4D TOMOTHERAPY : PRELIMINARY DOSIMETRIC ANALYSIS OF THE EFFECTS OF THE TARGET MOTION 6
Dedicata aCri
Multi-modality Imaging
4D WORKFLOW ANALYSIS - IMAGING & CONTOURING
Immobilization
Verify and Monitor Delivery
Deliver Treatment
Pre-Verify Dose/Position
Simulation
Forward PlanningTreatment setup
Dose computation
Inverse PlanningDefine Objectives
Optimize
Plan Analysis
Dose Accuracy
Target and Structure Definition
Image Patient
Adaptive Analysis
Delivery System QA
Export to Delivery System
Pretreatment CT Guidance
Modify Plan/Patient Position
Planning
4D Components
Delivery
Export for Population
4D Images (>1000)
4D Tools & Issues
4D ContouringPropagate ROIs?MIP Contouring?4D OARs Volume Deformations
04/08/23 G.GUIDI - M.AMADORI : 4D TOMOTHERAPY : PRELIMINARY DOSIMETRIC ANALYSIS OF THE EFFECTS OF THE TARGET MOTION 7
Dedicata aCri
4DCT AND GATING/TRACKING DEVICES(TOSHIBA + VISION RT)
Advantages:4DCT Exams (10 CT Dataset – 0-100% Breathing Phases): Very Fast (few minutes) – Retrospective ModeRange Slice thickness for our RT: 0.5 - 3 mm (5mm used for Cranio Spinal Irradiation and TBI)VisionRT detect capability: 1-2mm of the couch movement (VisionRT can appreciate the ramp up of the couch during the CT scan)Issues:4DCT Images Reconstruction (>1000 Images – 10 CT Datasets – 5/6 Hours of reconstruction)Thickness 0.5mm could be useful for Radiosurgery but dose issues and the Tomotherapy image resample (256x256) could create problemsTroubles and investigation:Mismatch image reconstruction due to the couch ramp-up and the breathing signal (Sinogramma Editing in develop by Toshiba)Limited Trigger Time of 10 cycles/min not applicable (No idea why ????)Work on Phases 20-60% (5 CT Datasets) - 2-3mm Slice ThicknessContour all CTVs and OARs using TPS (Not Applicable).During routine is contouring Min exhale and Max inhale phases, but is no equal to contour the CTVs for each phases
04/08/23 G.GUIDI - M.AMADORI : 4D TOMOTHERAPY : PRELIMINARY DOSIMETRIC ANALYSIS OF THE EFFECTS OF THE TARGET MOTION 8
Dedicata aCri
PINNACLE 4D RESEARCH CONSOLE
Contouring Objectives:Define contours that include all the organ and tumor movements due to the cyclesIssues:Contouring each phases is very long time consuming using standard TPS Advantages using Pinnacle 4D Console:Contouring the CTVs of the Multiple Phases (20-60%) and propagate ROI and OARs to all others 4DCT examsUse the Model Based Segmentation to speed up the contouring time Create an average MIP exams to accelerate the evaluation of the volumesCreate an ITV as integration of all the CTVs contoured in each phases
Beta Test Console: Courtesy of TA Tecnologie Avanzate
CT Movement Artifact(Lung or Liver)
04/08/23 G.GUIDI - M.AMADORI : 4D TOMOTHERAPY : PRELIMINARY DOSIMETRIC ANALYSIS OF THE EFFECTS OF THE TARGET MOTION 9
Dedicata aCri
FOCAL 4D RESEARCH CONSOLE
Contouring Objectives:Define contours that include all the organ and tumor movements due to the cyclesIssues:Contouring each phases is very long time consuming using standard TPSAdvantages using Focal 4D Console:Contouring the CTVs of the Multiple Phases (20-60%) using MIP CineContouring on axial, coronal and sagittal viewPropagate ROI and OARs to all others 4DCT examsCreate an ITV as integration of all the CTVs contoured in each phases
Beta Test Console: Courtesy of TEMA Sinergie
04/08/23 G.GUIDI - M.AMADORI : 4D TOMOTHERAPY : PRELIMINARY DOSIMETRIC ANALYSIS OF THE EFFECTS OF THE TARGET MOTION 10
Dedicata aCri
Multi-modality Imaging
4D WORKFLOW ANALYSIS – PLANNING & DOSE COMPUTATION
Immobilization
Verify and Monitor Delivery
Deliver Treatment
Pre-Verify Dose/Position
Simulation
Forward PlanningTreatment setup
Dose computation
Inverse PlanningDefine Objectives
Optimize
Plan Analysis
Dose Accuracy
Target and Structure Definition
Image Patient
Adaptive Analysis
Delivery System QA
Export to Delivery System
Pretreatment CT Guidance
Modify Plan/Patient Position
Planning
4D Components
Delivery
Export for Population
4D Images (>1000)
4D Tools & Issues
4D ContouringPropagate ROIs?MIP Contouring?4D OARs Volume Deformations
4D Planning (0-100% Phases)?4D Dose Computation – Phases?
4D Analysis (Multiple Plan)
4D Inverse Planning(Same results?)
04/08/23 G.GUIDI - M.AMADORI : 4D TOMOTHERAPY : PRELIMINARY DOSIMETRIC ANALYSIS OF THE EFFECTS OF THE TARGET MOTION 11
Dedicata aCri
Simulation of a 4D Lung treatmentCreate beamlets and plans for each phases and CTVs contoured (Total of 5 plans + 1 Plan for the ITV)Comparison of the multiple plans calculated on the CTVs vs. plan on the ITVQuestions?If I don’t use any margin to the CTV?Suspected under dosage of the ITV without 4D evaluation of the CTV or to the Target in general
ITV
CTV
4D PLANNING & 4D DOSE COMPUTATION
Question?
• Are there any clinical issues due to the target motion?
• Any implication on boost or BTV contoured without target motion evaluation?
• Any missing during a stereotactic treatment?
• Can I reduce CTV or ITV margins with Tomotherapy?
04/08/23 G.GUIDI - M.AMADORI : 4D TOMOTHERAPY : PRELIMINARY DOSIMETRIC ANALYSIS OF THE EFFECTS OF THE TARGET MOTION 12
Dedicata aCri
4D MULTIPLE PLAN EVALUATION
CTV20 (phase 20%)CTV30 (phase 30%)CTV40 (phase 40%)CTV50 (phase 50%)CTV60 (phase 60%)
ITV (phase 20%)ITV (phase 30%)ITV (phase 40%)ITV (phase 50%)ITV (phase 60%)
Upper Lobe Lesion & Small Volume 40% of Dose differences between CTV and ITV ...Question? Do I need a margin? Are enough accurate the voxel dimension for a 4DRT? (256x256)?
• Export Tomo Doses to CERR and process it• Long time consuming, but it is possible to evaluate and analyze multiple plan at the same time
CERR: Courtesy of Prof. Joseph Deasy – Prof. Issam El Naqa
Phase Dose Matrix Structure
Phases Dose Maps
04/08/23 G.GUIDI - M.AMADORI : 4D TOMOTHERAPY : PRELIMINARY DOSIMETRIC ANALYSIS OF THE EFFECTS OF THE TARGET MOTION 13
Dedicata aCri
4D MARGIN EVALUATION (4 PLANS : TARGET=PTV)
PTV=CTV
PTV=ITV
PTV=CTV+0.5cm
PTV=CTV+ 1cm
Suspected CTV Voxel Issue correlated to the dose grid or to the image resample : Under investigation
CTV
ITV
CTV
ITV
CTV
ITV
CTV
ITV
04/08/23 G.GUIDI - M.AMADORI : 4D TOMOTHERAPY : PRELIMINARY DOSIMETRIC ANALYSIS OF THE EFFECTS OF THE TARGET MOTION 14
Dedicata aCri
4D DOSE RECONSTRUCTION OF THE RESPIRATORY PHASES(Possible!!! But I will be crazy, if it will be a clinical routine (3 days of work))
4D DOSE RECONSTRUCTION
Dose Matrix (Phase 20%) +Dose Matrix (Phase 30%) +Dose Matrix (Phase 40%) +Dose Matrix (Phase 50%) +Dose Matrix (Phase 60%) +------------------------------------4D Dose Reconstruction
The breathing sinogramma will define the time (BIN) for each Dose Matrix
04/08/23 G.GUIDI - M.AMADORI : 4D TOMOTHERAPY : PRELIMINARY DOSIMETRIC ANALYSIS OF THE EFFECTS OF THE TARGET MOTION 15
Dedicata aCri
Multi-modality Imaging
4D QA
Immobilization
Verify and Monitor Delivery
Deliver Treatment
Pre-Verify Dose/Position
Simulation
Forward PlanningTreatment setup
Dose computation
Inverse PlanningDefine Objectives
Optimize
Plan Analysis
Dose Accuracy
Target and Structure Definition
Image Patient
Adaptive Analysis
Delivery System QA
Export to Delivery System
Pretreatment CT Guidance
Modify Plan/Patient Position
Planning
4D Components
Delivery
Export for Population
4D Images (>1000)
4D Tools & Issues
4D ContouringPropagate ROIs?MIP Contouring?4D OARs Volume Deformations
4D Planning (0-100% Phases)?4D Dose Computation – Phases?
4D Analysis (Multiple Plan)
4D QA (Dynamic Phantom)
4D Inverse Planning(Same results?)
04/08/23 G.GUIDI - M.AMADORI : 4D TOMOTHERAPY : PRELIMINARY DOSIMETRIC ANALYSIS OF THE EFFECTS OF THE TARGET MOTION 16
Dedicata aCri
Preliminary dosimetric issue of the Patient DQA using QUASAR PhantomRespiratory phases 15 cycles/min Active Target Simulation : 0.5 cm movement (Cranio – Caudal) during Tomo deliveryThe dynamic phantom has a dedicated Gaf-Chromic and Ion chamber insertDosimetric differences appraisal using Gaf-Chromic Film
X Coordinate: Edge of the CTV near the Gantry Y Coordinate: CTV Coronal Profile
LET’S GO TO THE QA AND ANALYZE THE REAL DOSES DELIVERED (DQA)THEORY AND PRACTICE COULD BE DIFFERENT
Dose measured and calculated are different and shifted, especially near the tumor edgesGamma Index 3%@3mm can help me ?
Calculated : 2.25 GyMeasured : 1.75 Gy
04/08/23 G.GUIDI - M.AMADORI : 4D TOMOTHERAPY : PRELIMINARY DOSIMETRIC ANALYSIS OF THE EFFECTS OF THE TARGET MOTION 17
Dedicata aCri
4D GAF CHROMIC ANALYSIS (GAMMA INDEX 3% @ 3mm)
Inside the target seems to be delivered an adequate dose..... but the dose at the border of the target looks very different from the
plan
Calculated : 2 Gy
Measured : 1.75 Gy
Can I accept the DQA?1. X - Y direction are not adequate2. Z –Y direction analysis can be
done using same method3. X-Y-Z direction at the same time
....not at the moment with this phantom
04/08/23 G.GUIDI - M.AMADORI : 4D TOMOTHERAPY : PRELIMINARY DOSIMETRIC ANALYSIS OF THE EFFECTS OF THE TARGET MOTION 18
Dedicata aCri
Which dose we deliver to the BTV (e.g. SIB or BTV Boost), without any extra margin.........maybe some active cancer cells inside, could be underdosed
Currently we are using PET for target definition, but we should evaluate the 4D CT/PET information•BTV definition•ITV definition (IBTV : Internal Biological Target Volume)•Windows Thresholds•Type of tracer•......
QUESTION ?WHICH IS THE DOSE DELIVERED DURING A BOOST OF THE BTV AND THERE ARE NO MARGINS OR ITV EVALUATION?
4D CT/PET : Work in progress
ITVCTV
4D CT/PET : Different case
04/08/23 G.GUIDI - M.AMADORI : 4D TOMOTHERAPY : PRELIMINARY DOSIMETRIC ANALYSIS OF THE EFFECTS OF THE TARGET MOTION 19
Dedicata aCri
Preliminary results using a dynamic Phantom (Quasar) Respiratory phases 15 cycles /minThe easiest sinogramma (periodic and constant - sinusoidal)Evaluate Cranial Caudal direction AnalysisTarget Movement: 1 cm
EVALUATE THE RESULTS
LET’S GO BACK TO PHANTOM AND LET’S TRY TO SIMPLIFY THE PROBLEMS
4D Motion Artifact(Should be a circle)
Equal Workflow but in a Phantom1. Acquire a4DCT Exams of the phantom2. Contour and define the inserts objects for each phases (Cube and
Spheres)3. Create multiple plan4. Evaluate the dose delivered using Gaf and Ion Chamber5. Analyze the easiest problem
EASY ANALYSIS CONDITIONDefined Direction
Defined Structures Revolutions and MovementsRigid Phantom
Defined Sinogramma
04/08/23 G.GUIDI - M.AMADORI : 4D TOMOTHERAPY : PRELIMINARY DOSIMETRIC ANALYSIS OF THE EFFECTS OF THE TARGET MOTION 20
Dedicata aCri
Preliminary results using a dynamic Phantom (Quasar) Respiratory phases 15 cycles /minCranial Caudal direction Analysis (4D Phantom can’t permit to analyze the X,Y,Z coordinate at the same time)Target Movement: 1 cmMorphing of the structures (4D Issue and Investigation)
Dosimetric impact of the structure morphing
due to respiratory motionDose Shift 1cm
Cranial under dosage and caudal over-dosage should be consideredDosimetric results on Gaf-Chromic: shift of 1cm (Cranial Caudal direction)
MODERATE DOSE DIFFERENCESBUT GAMMA INDEX AND DOSE ACCURACY NOT ACCEPTABLE FOR A PATIENT TREATMENT
TRY TO SIMPLIFY THE PROBLEMS .... VERY SIMILAR RESULTS
Gamma Index due to respiratory motion
04/08/23 G.GUIDI - M.AMADORI : 4D TOMOTHERAPY : PRELIMINARY DOSIMETRIC ANALYSIS OF THE EFFECTS OF THE TARGET MOTION 21
Dedicata aCri
Multi-modality Imaging
4D ADAPTIVE RADIATION THERAPY
Immobilization
Verify and Monitor Delivery
Deliver Treatment
Pre-Verify Dose/Position
Simulation
Forward PlanningTreatment setup
Dose computation
Inverse PlanningDefine Objectives
Optimize
Plan Analysis
Dose Accuracy
Target and Structure Definition
Image Patient
Adaptive Analysis
Delivery System QA
Export to Delivery System
Pretreatment CT Guidance
Modify Plan/Patient Position
Planning
4D Components
Delivery
Export for Population
4D Images (>1000)
4D Tools & Issues
4D ContouringPropagate ROIs?MIP Contouring?4D OARs Volume Deformations
4D Planning (0-100% Phases)?4D Dose Computation – Phases?
4D Analysis (Multiple Plan)
4D QA (Dynamic Phantom)
4D Gamma Index?4D Dose Point?4D Edge Profile?Accuracy?
4D Inverse Planning(Same results?)
Which Plan or Phases?
Which Phases to be consider?
Trigger Tomotherapy is possible?
4D-MVCT?
Tracking the delivery
4D Adaptive RT Reconstruction
NO ANSWER AT THE MOMENT...... BUT FEW IDEAS TO USE MVCT
04/08/23 G.GUIDI - M.AMADORI : 4D TOMOTHERAPY : PRELIMINARY DOSIMETRIC ANALYSIS OF THE EFFECTS OF THE TARGET MOTION 22
Dedicata aCri
4DCT AND PATHOLOGY EXAMS (JUST TO COMPLICATE THE PROBLEMS) (LUNG INVESTIGATION – COLLBORATION WITH CNAO)
Anatomy-Pathology exam before formalin
Anatomy-Pathology exam after formalin
1. Compare the tumor shrinking (from formalin)2. Analyze 4DCT studies and define rotational – translation matrix3. Analyze 4DCT studies and define the volume evolution during
breathing acts4. Merge CT and Anatomy-Pathology exam5. Try to confirm PET and MRI (not for lung) contouring6. Working with CNAO Groups to compare Treatments with Protons
and Carbon Ions and Gating Radiation Therapy
… Dynamic IMRT Treatment of the lesions using robotic couch or Tomotherapy....
.... if the 4D or the technology will be available....
Group Coordinator : Prof. Lorenzo Magno
CNAO Work-Group for Lung Carcinoma (NOC)Radiotherapy: Filippo Bertoni : [email protected] Bignardi : [email protected] Luigi Franco Cazzaniga : [email protected] Frezza : [email protected] Salvi. [email protected] Scorsetti :[email protected] ...Medical Physics:Gabriele Guidi: [email protected] Palombarini: [email protected]:Giulio Rossi: [email protected]:Maria Grazia Amorico: A .Ospedaliero-Universitaria di ModenaEnnio Gallo : [email protected] Torricelli: [email protected] Medicine:Bruno Bagni: Università degli Studi di Modena e Reggio EmiliaPneumology:Mario Bavieri: U.O. di Pneumologia , A .Ospedaliero-Universitaria di ModenaEmmanuela Meschiari: U.O. di Pneumologia, A .Ospedaliero-Universitaria di ModenaTorax Surgery:Corrado Lavini [email protected] Morandi: Università degli Studi di Modena e Reggio EmiliaOncology:Fausto Bavieri: U.O. di Oncologia, A .Ospedaliero-Universitaria di ModenaPsychologyAnnamaria Bonardi [email protected]:Roberto D’Amico: Ufficio Trial Dip. di Onc. ed Ematol., A. Ospedaliero-Universitaria di Modena
Work in Progress : Gabriele Guidi – Giulio Rossi
04/08/23 G.GUIDI - M.AMADORI : 4D TOMOTHERAPY : PRELIMINARY DOSIMETRIC ANALYSIS OF THE EFFECTS OF THE TARGET MOTION 23
Dedicata aCri
Conclusions
Special Thanks to Elisa & Luciano
1. 4D could be applicable by any center with a 4DCT and a tracking device
2. Long time consuming (imaging, contouring, plan, dose and QA) especially without 4D Tools
3. Many open issues, about dosimetry (Shift and Under-dosage)4. Evident missing at the border of the target (do we need specific
target margin?)5. Target motions has a big influences on the real doses delivered
(Anatomical missing and potential failure of the RT)6. 4D dose reconstruction could help to analyze the results 7. ITV can guaranties a partial margin reduction8. 4D with Tomotherapy: necessary to use ITV or adequate margin
to the target and analyze carefully your clinical objective, before to treat patient
4D work with time.........we need time to investigate the problems......but patience and any help could be important!!
4D
PhysicistDoctors
Will I see a 4D Tomotherapy Treatment?
EMEA 2009 Tomotherapy User Meeting 4D TOMOTHERAPY : PRELIMINARY DOSIMETRIC ANALYSIS OF THE EFFECTS OF THE TARGET MOTION G.Guidi1, M.Amadori2, E.Cenacchi1, L.Morini1, C.Danielli1, F.Bertoni2